← Evidence map

ArticleMolecular cancer2024

Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer.

Fei Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38183152